A unique expression pattern of LAG3 distinct from that of other immune checkpoints in diffuse large B‐cell lymphoma
Abstract Background Although some patients with diffuse large B‐cell lymphoma (DLBCL) show a response to immunotherapy, there are still many who do not respond. This suggests that various immune checkpoints are complicatedly intertwined in the composition of the tumor microenvironment of DLBCL. Pati...
Main Authors: | Hyunjee Lee, Sang Eun Yoon, Seok Jin Kim, Won Seog Kim, Junhun Cho |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.6268 |
Similar Items
-
PD-1 and LAG-3 Checkpoint Blockade: Potential Avenues for Therapy in B-Cell Lymphoma
by: Joshua W. D. Tobin, et al.
Published: (2021-05-01) -
CD8+ T Lymphocytes Immune Depletion and LAG-3 Overexpression in Hodgkin Lymphoma Tumor Microenvironment Exposed to Anti-PD-1 Immunotherapy
by: Jean-Marie Michot, et al.
Published: (2021-10-01) -
PD-1 and LAG-3 expression in EBV-associated pediatric Hodgkin lymphoma has influence on survival
by: Oscar Jimenez, et al.
Published: (2022-08-01) -
Tackling the dysregulated immune-checkpoints in classical Hodgkin lymphoma: bidirectional regulations between the microenvironment and Hodgkin/Reed-Sternberg cells
by: Alessandro Cellini, et al.
Published: (2023-05-01) -
LAG3: The Biological Processes That Motivate Targeting This Immune Checkpoint Molecule in Human Cancer
by: Cinzia Solinas, et al.
Published: (2019-08-01)